Fasting-mimicking diet with chemotherapy for ovarian cancer
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial studies whether a carefully planned “fasting-mimicking” diet can be safely added to chemotherapy for people with advanced ovarian, fallopian tube, or primary peritoneal cancer. It may help improve how the body handles treatment, but you must meet specific nutrition and cancer-response criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have advanced ovarian/fallopian tube/primary peritoneal cancer, and be planned for chemotherapy before surgery (neoadjuvant) or have cancer that came back after at least 6 months from the last platinum chemotherapy
- Your daily functioning level (ECOG) must be 0, 1, or 2—meaning you’re able to care for yourself and do light activities
- Have adequate blood counts, including enough white blood cells (ANC) and platelets
- Have enough kidney and liver function based on recent lab tests, and BMI at least 19
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether short-term fasting before chemotherapy is better than eating freely for women with advanced ovarian cancer. It aims to see if fasting can help treatment work better or reduce side effects.
This trial studies whether a structured exercise and lifestyle (diet and activity) program can help women with ovarian or endometrial cancer during chemotherapy. You may be assigned to the lifestyle program or usual care to compare outcomes.
This trial tests a different way of giving chemotherapy to people with advanced ovarian cancer that didn't respond well to initial treatment. The goal is to see if changing the dose and schedule can improve outcomes.
This trial tests whether alternating between a fasting day and a normal eating day can help people recovering from gynecologic cancer surgery while they receive chemotherapy. It aims to see if this eating pattern is safe and helpful during treatment.
This trial tests whether adding periods of fasting to standard chemotherapy before surgery helps people with advanced ovarian cancer. It is for those receiving platinum-based chemo for the first time or after recurrence.
This trial tests whether adding a special low-calorie diet (called a fasting-mimicking diet) to standard chemotherapy and immunotherapy can help treat triple-negative breast cancer before surgery. It aims to see if this combination makes the treatment work better.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.